| المؤلفون: |
Chipps BE; Capital Allergy & Respiratory Disease Center, Sacramento, CA, United States., Papi A; Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy., Beasley R; Medical Research Institute of New Zealand, Wellington, New Zealand; Capital and Coast District Health Board, Wellington, New Zealand; Victoria University Wellington, Wellington, New Zealand., Israel E; Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA., Panettieri RA Jr; Rutgers Institute for Translational Medicine and Science, Child Health Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Albers FC; Avillion US Inc., Northbrook, IL, United States., Cooper M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Darken P; Late Respiratory and Immunology Biometrics, AstraZeneca, Gaithersburg, MD, USA., Gilbert I; BioPharmaceuticals, US Medical, AstraZeneca, Wilmington, DE, United States., Trudo F; BioPharmaceuticals, US Medical, AstraZeneca, Wilmington, DE, United States., Weinberg M; Avillion US Inc., Northbrook, IL, United States., Cappelletti C; BioPharmaceuticals R&D, AstraZeneca, Durham, NC, United States. Electronic address: christycappelletti@att.net. |
Full Text via ClinicalKey 
Full Text Finder